RUNX1 and acute myeloid leukemia: Acute myelogenous leukemia (AML)-M2b, characterized by the (8;21)(q22;q22) translocation leading to the RUNX1::RUNX1T1 (AML1-ETO) fusion gene, exhibits unique biological features that predispose to extramedullary relapse and treatment resistance.